Skip to main content

Advertisement

SpringerLink
Log in

An individual patient data meta-analysis on characteristics, treatments and outcomes of the glioblastoma/gliosarcoma patients with central nervous system metastases reported in literature until 2013

  • Topic Review
  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

Dissemination of high-grade gliomas (WHO IV) has been investigated poorly so far. We conducted an extensive analysis of the characteristics, treatments and outcomes of the glioblastoma multiforme (GBM)/gliosarcoma (GS) patients with central nervous system (CNS) metastases reported in literature until April 2013. PubMed and Web of Science searches for peer-reviewed articles pertaining to GBM/GS patients with metastatic disease were conducted using predefined keywords. Additionally, we performed hand search following the references from the selected papers. Cases in which the metastases exclusively occurred outside the CNS were excluded. 110 publications reporting on 189 patients were eligible. There was a significant increase in the number of reported cases over the last decades. We calculated a median overall survival from diagnosis of metastasis (from initial diagnosis of GBM/GS) of 3.0 ± 0.3 (11 ± 0.7) months. On univariate analyses, gender, age, the histological subtype, the time interval between initial diagnosis and the occurrence of metastases and the location of CNS metastasis (intracranial versus spinal and parenchymal versus leptomeningeal, respectively) did not influence survival after diagnosis of metastasis. There was no substantial treatment progress over the recent decades. GBM/GS with CNS metastasis are associated with a dismal prognosis. Crucial treatment progress is not evident. A central registry should be considered to consecutively gain more information about the ideal therapeutic approach.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Gebhardt BJ, Dobelbower MC, Ennis WH, Bag AK, Markert JM, Fiveash JB (2014) Patterns of failure for glioblastoma multiforme following limited-margin radiation and concurrent temozolomide. Radiat Oncol 9:130. doi:10.1186/1748-717X-9-130

    Article  PubMed Central  PubMed  Google Scholar 

  2. Vertosick FT Jr, Selker RG (1990) Brain stem and spinal metastases of supratentorial glioblastoma multiforme: a clinical series. Neurosurgery 27 (4):516–521; discussion 521–512

  3. Tendulkar RD, Pai Panandiker AS, Wu S, Kun LE, Broniscer A, Sanford RA, Merchant TE (2010) Irradiation of pediatric high-grade spinal cord tumors. Int J Radiat Oncol Biol Phys 78(5):1451–1456. doi:10.1016/j.ijrobp.2009.09.071

    Article  PubMed  Google Scholar 

  4. Müller K, Schlamann A, Guckenberger M, Warmuth-Metz M, Gluck A, Pietschmann S, Wawer A, Kortmann RD, Kramm C, von Bueren AO (2014) Craniospinal irradiation with concurrent temozolomide for primary metastatic pediatric high-grade or diffuse intrinsic pontine gliomas. A first report from the GPOH-HIT-HGG Study Group. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft [et al] 190 (4):377–381. doi:10.1007/s00066-013-0513-0

  5. Moher D, Liberati A, Tetzlaff J, Altman DG, Group P (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol 62(10):1006–1012. doi:10.1016/j.jclinepi.2009.06.005

    Article  Google Scholar 

  6. Chang CH, Housepian EM, Herbert C Jr (1969) An operative staging system and a megavoltage radiotherapeutic technic for cerebellar medulloblastomas. Radiology 93(6):1351–1359

    Article  CAS  PubMed  Google Scholar 

  7. Stupp R, Mason WP, van Den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO, European Organisation for R, Treatment of Cancer Brain T, Radiotherapy G, National Cancer Institute of Canada Clinical Trials G (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. New Engl J Med 352(10):987–996. doi:10.1056/NEJMoa043330

    Article  CAS  PubMed  Google Scholar 

  8. Kalokhe G, Grimm SA, Chandler JP, Helenowski I, Rademaker A, Raizer JJ (2012) Metastatic glioblastoma: case presentations and a review of the literature. J Neuro Oncol 107(1):21–27. doi:10.1007/s11060-011-0731-1

    Article  Google Scholar 

  9. Shahideh M, Fallah A, Munoz DG, Loch Macdonald R (2012) Systematic review of primary intracranial glioblastoma multiforme with symptomatic spinal metastases, with two illustrative patients. J Clin Neurosci 19(8):1080–1086. doi:10.1016/j.jocn.2011.09.024

    Article  PubMed  Google Scholar 

  10. Lawton CD, Nagasawa DT, Yang I, Fessler RG, Smith ZA (2012) Leptomeningeal spinal metastases from glioblastoma multiforme: treatment and management of an uncommon manifestation of disease. J Neurosurg Spine 17(5):438–448. doi:10.3171/2012.7.SPINE12212

    Article  PubMed  Google Scholar 

  11. Maslehaty H, Cordovi S, Hefti M (2011) Symptomatic spinal metastases of intracranial glioblastoma: clinical characteristics and pathomechanism relating to GFAP expression. J Neuro Oncol 101(2):329–333. doi:10.1007/s11060-010-0257-y

    Article  Google Scholar 

  12. Lindsay A, Holthouse D, Robbins P, Knuckey N (2002) Spinal leptomeningeal metastases following glioblastoma multiforme treated with radiotherapy. J Clin Neurosci 9(6):725–728

    Article  PubMed  Google Scholar 

  13. MacDonald TJ, Aguilera D, Kramm CM (2011) Treatment of high-grade glioma in children and adolescents. Neuro Oncol 13(10):1049–1058. doi:10.1093/neuonc/nor092

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  14. Galanis E, Buckner JC, Dinapoli RP, Scheithauer BW, Jenkins RB, Wang CH, O’Fallon JR, Farr G Jr (1998) Clinical outcome of gliosarcoma compared with glioblastoma multiforme: North Central Cancer Treatment Group results. J Neurosurg 89(3):425–430. doi:10.3171/jns.1998.89.3.0425

    Article  CAS  PubMed  Google Scholar 

  15. Jenkin D, Shabanah MA, Shail EA, Gray A, Hassounah M, Khafaga Y, Kofide A, Mustafa M, Schultz H (2000) Prognostic factors for medulloblastoma. Int J Radiat Oncol Biol Phys 47(3):573–584

    Article  CAS  PubMed  Google Scholar 

  16. Zwiener I, Blettner M, Hommel G (2011) Survival analysis: part 15 of a series on evaluation of scientific publications. Deutsches Arzteblatt Int 108(10):163–169. doi:10.3238/arztebl.2010.0163

    Google Scholar 

  17. Brat DJ, Ryken TC, Kalkanis SN, Olson JJ, Committee ACJG (2014) The role of neuropathology in the management of progressive glioblastoma : a systematic review and evidence-based clinical practice guideline. J Neuro Oncol 118(3):461–478. doi:10.1007/s11060-013-1331-z

    Article  CAS  Google Scholar 

  18. Olson JJ, Nayak L, Ormond DR, Wen PY, Kalkanis SN, Committee ACJG (2014) The role of cytotoxic chemotherapy in the management of progressive glioblastoma : a systematic review and evidence-based clinical practice guideline. J Neuro Oncol 118(3):501–555. doi:10.1007/s11060-013-1338-5

    Article  CAS  Google Scholar 

  19. Olson JJ, Nayak L, Ormond DR, Wen PY, Kalkanis SN, Ryken TC, Committee ACJG (2014) The role of targeted therapies in the management of progressive glioblastoma : a systematic review and evidence-based clinical practice guideline. J Neuro Oncol 118(3):557–599. doi:10.1007/s11060-013-1339-4

    Article  CAS  Google Scholar 

  20. Ryken TC, Aygun N, Morris J, Schweizer M, Nair R, Spracklen C, Kalkanis SN, Olson JJ, Committee ACJG (2014) The role of imaging in the management of progressive glioblastoma : a systematic review and evidence-based clinical practice guideline. J Neuro Oncol 118(3):435–460. doi:10.1007/s11060-013-1330-0

    Article  CAS  Google Scholar 

  21. Ryken TC, Kalkanis SN, Buatti JM, Olson JJ, Committee ACJG (2014) The role of cytoreductive surgery in the management of progressive glioblastoma : a systematic review and evidence-based clinical practice guideline. J Neuro Oncol 118(3):479–488. doi:10.1007/s11060-013-1336-7

    Article  Google Scholar 

  22. Ryu S, Buatti JM, Morris A, Kalkanis SN, Ryken TC, Olson JJ, Committee ACJG (2014) The role of radiotherapy in the management of progressive glioblastoma : a systematic review and evidence-based clinical practice guideline. J Neuro Oncol 118(3):489–499. doi:10.1007/s11060-013-1337-6

    Article  CAS  Google Scholar 

  23. Blettner M, Schlehofer B, Sauerbrei W (1997) Limitations of meta-analysis from published data in epidemiological research. Soz Praventivmed 42(2):95–104

    Article  CAS  PubMed  Google Scholar 

  24. Mazloom A, Hodges JC, Teh BS, Chintagumpala M, Paulino AC (2012) Outcome of patients with pilocytic astrocytoma and leptomeningeal dissemination. Int J Radiat Oncol Biol Phys 84(2):350–354. doi:10.1016/j.ijrobp.2011.12.044

    Article  PubMed  Google Scholar 

  25. Müller K, Diez B, Muggeri A, Pietsch T, Friedrich C, Rutkowski S, von Hoff K, von Bueren AO, Zwiener I, Bruns F (2013) What’s in a name? Intracranial peripheral primitive neuroectodermal tumors and CNS primitive neuroectodermal tumors are not the same. Strahlenther Onkol 189(5):372–379. doi:10.1007/s00066-013-0315-4

    Article  PubMed  Google Scholar 

  26. Moergel M, Meurer P, Ingel K, Wendt TG, Al-Nawas B (2011) Effectiveness of postoperative radiotherapy in patients with small oral and oropharyngeal squamous cell carcinoma and concomitant ipsilateral singular cervical lymph node metastasis (pN1): a meta-analysis. Strahlenther Onkol 187(6):337–343. doi:10.1007/s00066-011-2206-x

    Article  PubMed  Google Scholar 

  27. Erpolat OP, Gocun PU, Akmansu M, Ozgun G, Akyol G (2013) Hypoxia-related molecules HIF-1alpha, CA9, and osteopontin : predictors of survival in patients with high-grade glioma. Strahlenther Onkol 189(2):147–154. doi:10.1007/s00066-012-0262-5

    Article  CAS  PubMed  Google Scholar 

  28. Murphy M, Parney IF (2014) Clinical trials in neurosurgical oncology. J Neuro Oncol. doi:10.1007/s11060-014-1569-0

    Google Scholar 

Download references

Acknowledgments

We are indebted to the authors of articles, who provided the data to this study that otherwise would have not been possible. We would like to thank Mrs. Christiane Hofmann for assisting the literature search.

Conflict of interest

The author(s) indicated no potential conflicts of interest.

Ethical standards

This manuscript is in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its subsequent amendments.

Author information

Authors and Affiliations

  1. Department for Radiation Oncology, University of Leipzig Medical Center, Stephanstraße 9a, 04103, Leipzig, Germany

    Sophie Pietschmann, Michael Josef Kerber, Rolf-Dieter Kortmann & Klaus Müller

  2. Division of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine, University Medical Center Goettingen, Goettingen, Germany

    André O. von Bueren

  3. Department of Radiation Oncology, Kantonsspital St. Gallen, Rorschacherstrasse 95, 9007, St. Gallen, Switzerland

    Guido Henke

  4. Strahlentherapie Uniklinik Leipzig, Stephanstr. 9a, 04103, Leipzig, Germany

    Klaus Müller

Authors
  1. Sophie Pietschmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. André O. von Bueren
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Guido Henke
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Michael Josef Kerber
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Rolf-Dieter Kortmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Klaus Müller
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Klaus Müller.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (PDF 486 kb)

Supplementary material 2 (DOCX 30 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pietschmann, S., von Bueren, A.O., Henke, G. et al. An individual patient data meta-analysis on characteristics, treatments and outcomes of the glioblastoma/gliosarcoma patients with central nervous system metastases reported in literature until 2013. J Neurooncol 120, 451–457 (2014). https://doi.org/10.1007/s11060-014-1596-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11060-014-1596-x

Keywords

Search

Navigation